Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-19
DOI
10.1038/s41467-017-01236-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway
- (2017) Liu-Ya Tang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Strategies and Approaches of Targeting STAT3 for Cancer Treatment
- (2016) Steffanie L. Furtek et al. ACS Chemical Biology
- Biomarkers in systemic sclerosis: Their potential to predict clinical courses
- (2016) Minoru Hasegawa JOURNAL OF DERMATOLOGY
- Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
- (2016) Hanane Laklai et al. NATURE MEDICINE
- Noncanonical STAT3 Activation Regulates Excess TGF-β1 and Collagen I Expression in Muscle of Stricturing Crohn’s Disease
- (2015) Chao Li et al. JOURNAL OF IMMUNOLOGY
- Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
- (2015) Katrin Palumbo-Zerr et al. NATURE MEDICINE
- Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
- (2015) Nadira Ruzehaji et al. ARTHRITIS RESEARCH & THERAPY
- Stat3 signaling activation crosslinking of TGF-β1 in hepatic stellate cell exacerbates liver injury and fibrosis
- (2014) Ming-Yi Xu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells
- (2014) Nathalie Schmitt et al. NATURE IMMUNOLOGY
- Correction: Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
- (2014) Ausra Milano et al. PLoS One
- 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
- (2013) Frank van den Hoogen et al. ARTHRITIS AND RHEUMATISM
- A Novel Role of the STAT3 Pathway in Brain Inflammation-induced Human Neural Progenitor Cell Differentiation
- (2013) E. Chen et al. CURRENT MOLECULAR MEDICINE
- Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation
- (2013) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NF-κB and STAT3 Inhibition as a Therapeutic Strategy in Psoriasis: In Vitro and In Vivo Effects of BTH
- (2013) Rosa M. Andrés et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- STAT3 Phosphorylation at Tyrosine 705 and Serine 727 Differentially Regulates Mouse ESC Fates
- (2013) Guanyi Huang et al. STEM CELLS
- Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis
- (2012) Nicole Reich et al. ANNALS OF THE RHEUMATIC DISEASES
- JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis
- (2012) Clara Dees et al. ARTHRITIS AND RHEUMATISM
- TGFβ signalling in context
- (2012) Joan Massagué NATURE REVIEWS MOLECULAR CELL BIOLOGY
- JNK-Dependent Stat3 Phosphorylation Contributes to Akt Activation in Response to Arsenic Exposure
- (2012) J. Liu et al. TOXICOLOGICAL SCIENCES
- Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
- (2012) Alfiya Akhmetshina et al. Nature Communications
- Biomarkers for skin involvement and fibrotic activity in scleroderma
- (2011) P. Moinzadeh et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis
- (2010) G. Farina et al. ARTHRITIS AND RHEUMATISM
- Animal models of systemic sclerosis: Prospects and limitations
- (2010) Christian Beyer et al. ARTHRITIS AND RHEUMATISM
- Biomarkers in systemic sclerosis
- (2010) Susan V Castro et al. Biomarkers in Medicine
- Stat3 as a Therapeutic Target for the Treatment of Psoriasis: A Clinical Feasibility Study with STA-21, a Stat3 Inhibitor
- (2010) Ken Miyoshi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy
- (2010) Maoyin Pang et al. KIDNEY INTERNATIONAL
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- Jnk signaling pathway-mediated regulation of Stat3 activation is linked to the development of doxorubicin resistance in cancer cell lines
- (2009) Ju-Hwa Kim et al. BIOCHEMICAL PHARMACOLOGY
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner
- (2009) A. Chaudhry et al. SCIENCE
- Src kinases in systemic sclerosis: Central roles in fibroblast activation and in skin fibrosis
- (2008) Catherine Skhirtladze et al. ARTHRITIS AND RHEUMATISM
- Effects of Plasmid-Based Stat3-Specific Short Hairpin RNA and GRIM-19 on PC-3M Tumor Cell Growth
- (2008) L. Zhang et al. CLINICAL CANCER RESEARCH
- Antitransforming growth factor-β therapy in fibrosis: recent progress and implications for systemic sclerosis
- (2008) John Varga et al. CURRENT OPINION IN RHEUMATOLOGY
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
- (2008) Alfiya Akhmetshina et al. FASEB JOURNAL
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started